Gaetano Cairo’s doped science
Smut Clyde is back to Milan, to show you some more artworks exhibited at the Institute of General Pathology. He will give you a quick run of Gaetano Cairo’s doped science.
Tag: cancer research
Alfonsina Desiderio and her pathological Bully Boys
Smut Clyde and Clare Francis studied the works of Milanese cancer researchers around Maria Alfonsina Desiderio. There are even ideas for T-shirts!
Editorial gatekeepers mind their own goals
This guest post by “Morty” will show you some useful life hacks to boost your publication output. To qualify however, you must be Editor-in-Chief or at least editorial board member, preferably with Elsevier.
Misconduct findings fell KI Vice-President Dahlman-Wright
Karolinska Vice-president Karin Dahlman-Wright was found guilty of research misconduct, not much, only in one case, and even that shared. But she already resigned.
David Latchman, uncensored
I publish exclusively two uncensored UCL screening panel reports into the David Latchman and Anastasis Stephanou affair. Now we know which papers were investigated and which requested retractions didn’t happen.
Sanofi R&D Head John Reed knows how to science
In 2018, the pharma giant Sanofi appointed with John Reed a new R&D head. Apparently Sanofi does not believe in PubPeer.
Floppy “Goebels” Zauli and the fascists of Ferrara
University of Ferrara rejected a journalist’s FOI request about the investigation of its own Rector. The arguments: the media is biased and drives a slander campaign against Giorgio Zauli, and in any case, his research can only be evaluated in a “Science Court” by peer review.
Richard Hill, the man even gels are afraid of
Get ready to meet Dr Richard Hill and his amazing jumping blots. Just don’t stare, or you’ll get hurt.
Pier Paolo and Pier Giuseppe, the titans of IFOM-IEO
Meet two grand cancer researchers from Milan: Pier Paolo Di Fiore and Pier Giuseppe Pelicci. Then decide if you want to give them your tax and charity money.
Blagosklonny’s lawyer threatens me to love Oncotarget or else
Oncotarget, the somewhat controversial OA journal, switched from pretend-soliciting my services to threatening to sue me for defamation. Their lawyer writes my disrespect caused them financial damage.
For Better Science 